Tag: OOS investigation checklist

Regulatory Guidelines for Reporting OOS in Stability Studies

Out-of-Specification (OOS) results in stability studies are critical indicators that a pharmaceutical product may no longer meet its intended quality attributes. Regulatory agencies across the globe, including the USFDA, EMA, and CDSCO, have strict requirements for how these deviations should be identified, investigated, and reported. This article provides a comprehensive look at the regulatory framework…

Deviation and OOS Handling in Stability Testing, Pharmaceutical Quality and Practices

Checklist for OOS Handling Procedures in Stability Testing

Handling Out-of-Specification (OOS) results in pharmaceutical stability testing requires a disciplined and compliant approach. Regulatory bodies like the USFDA expect companies to follow well-documented and scientifically justified procedures to investigate and resolve OOS results without compromising data integrity. This checklist outlines a step-by-step framework to guide your team through proper OOS handling. ✅ Phase I:…

Deviation and OOS Handling in Stability Testing, Pharmaceutical Quality and Practices